Evidence map›Paper›PMID 28150104›Full record

ArticleClinical rheumatology2017

Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.

Dionicio A Galarza-Delgado, Jose R Azpiri-Lopez, Iris J Colunga-Pedraza, Jesus A Cardenas-de la Garza, Raymundo Vera-Pineda, Griselda Serna-Peña, Rosa I Arvizu-Rivera, Adrian Martinez-Moreno, Martin Wah-Suarez, Mario A Garza Elizondo

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dionicio A Galarza-DelgadoInternal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico. dgalarza@medicinauanl.mx.
Jose R Azpiri-LopezInternal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Iris J Colunga-PedrazaInternal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Jesus A Cardenas-de la GarzaInternal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Raymundo Vera-PinedaInternal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Griselda Serna-PeñaInternal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Rosa I Arvizu-RiveraInternal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Adrian Martinez-MorenoInternal Medicine Department, Cardiology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Martin Wah-SuarezInternal Medicine Department, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.
Mario A Garza ElizondoInternal Medicine Department, Rheumatology Division, University Hospital Dr. Jose Eleuterio Gonzalez UANL, Francisco I. Madero y Gonzalitos S/N, 64460, Monterrey, Nuevo Leon, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Variability of the 10-year cardiovascular (CV) risk predicted by the Framingham Risk Score (FRS) using lipids, FRS using body mass index (BMI), Reynolds Risk Score (RRS), QRISK2, Extended Risk Score-Rheumatoid Arthritis (ERS-RA), and algorithm developed by the American College of Cardiology and the American Heart Association in 2013 (ACC/AHA 2013) according to the European League Against Rheumatism (EULAR) 2015/2016 update of its evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis (RA) has not been evaluated in Mexican mestizo patients. CV risk was predicted using six different risk calculators in 116 patients, aged 40-75, who fulfilled the ACR/EULAR 2010 classification criteria. Results were multiplied by 1.5 according to the EULAR 2015/2016 update. Global comparison of the risk predicted by all scales was done using the Friedman test, considering a P value of ≤0.05 as statistically significant. Individual comparison between the algorithms was made using the Wilcoxon signed-rank test, and a P value of ≤0.003 was considered statistically significant. All calculators showed to be different in the Friedman test (p ≤ 0.001). Median values of predicted 10-year CV risk were 11.02% (6.18-17.55) for FRS BMI; 8.47% (4.6-13.16) for FRS lipids; 5.55% (2.5-11.85) for QRISK2; 5% (3.1-8.65) for ERS-RA; 3.6% (1.5-9.3) for ACC/AHA 2013; and 1.5% (1.5-4.5) for RRS. ERS-RA showed no difference when compared against QRISK2 (p = 0.269). CV risk calculators showed variability among them and cannot be used indistinctly in RA-patients.

Indexed as

AgedArthritis, RheumatoidCardiovascular DiseasesCross-Sectional StudiesFemaleHumansMaleMexicoMiddle AgedRisk AssessmentCardiovascular diseasesRheumatoid arthritisRisk assessment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.